Oncology & Cancer
Benefits of radionuclide therapy for neuroendocrine tumors
According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate) , is effective not only in ...
Sep 20, 2011
1
0
